当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 现金流量表

泰格医药

(300347)

  

流通市值:328.40亿  总市值:499.40亿
流通股本:5.66亿   总股本:8.61亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,377,830,010.851,630,273,549.066,785,119,210.174,856,126,172.22
  收到的税费返还478,422.27308,078.91615,206.982,149,719.16
  收到其他与经营活动有关的现金44,497,393.3521,898,964.34175,028,505.84135,443,635.26
  经营活动现金流入小计3,422,805,826.471,652,480,592.316,960,762,922.994,993,719,526.64
  购买商品、接受劳务支付的现金983,894,406.19473,163,748.751,960,341,102.441,378,495,566.27
  支付给职工以及为职工支付的现金1,602,792,496.76772,187,943.293,123,669,809.042,298,577,074.56
  支付的各项税费203,828,742.6996,528,524.28524,720,429.49436,973,562.51
  支付其他与经营活动有关的现金223,671,172.89112,665,761.81255,029,678.28300,903,713.35
  经营活动现金流出小计3,014,186,818.531,454,545,978.135,863,761,019.254,414,949,916.69
  经营活动产生的现金流量净额408,619,007.94197,934,614.181,097,001,903.74578,769,609.95
二、投资活动产生的现金流量:
  收回投资收到的现金1,029,475,120.59117,616,398.622,088,507,799.04619,025,446.77
  取得投资收益收到的现金21,077,608.3631,280,078.1362,540,443.5833,510,950.69
  处置固定资产、无形资产和其他长期资产收回的现金净额2,016,43934,718.32,335,687.89188,383.44
  收到的其他与投资活动有关的现金6,423,003.841,158.7917,676,031.214,687,103.15
  投资活动现金流入小计1,058,992,171.79148,932,353.842,171,059,961.71667,411,884.05
  购建固定资产、无形资产和其他长期资产支付的现金100,831,158.1248,094,554.92356,554,496.96278,061,741.81
  投资支付的现金874,389,321.69747,793,521.76,176,067,436.976,091,185,860.3
  取得子公司及其他营业单位支付的现金2,258,635.582,258,635.58367,354,142.1920,964,321.47
  支付其他与投资活动有关的现金35,623,0008,654,88010,206,300316,860
  投资活动现金流出小计1,013,102,115.39806,801,592.26,910,182,376.126,390,528,783.58
  投资活动产生的现金流量净额45,890,056.4-657,869,238.36-4,739,122,414.41-5,723,116,899.53
三、筹资活动产生的现金流量:
  吸收投资收到的现金92,600,00062,600,00078,560,00061,900,000
  其中:子公司吸收少数股东投资收到的现金92,600,000---
  取得借款收到的现金1,009,796,907.23555,356,0003,379,458,927.12,843,516,597.92
  收到其他与筹资活动有关的现金--128,097,800.76107,255,379.29
  筹资活动现金流入小计1,102,396,907.23617,956,0003,586,116,727.863,012,671,977.21
  偿还债务支付的现金1,235,205,515.51319,007,7483,880,222,821.922,035,406,823.68
  分配股利、利润或偿付利息支付的现金288,157,666.7427,059,863.38642,156,083.35608,854,337.03
  其中:子公司支付给少数股东的股利、利润16,655,591.75---
  支付其他与筹资活动有关的现金405,984,045.92375,754,195.12766,148,050.22640,412,502.45
  筹资活动现金流出小计1,929,347,228.17721,821,806.55,288,526,955.493,284,673,663.16
  筹资活动产生的现金流量净额-826,950,320.94-103,865,806.5-1,702,410,227.63-272,001,685.95
四、汇率变动对现金及现金等价物的影响14,360,075.824,959,416.33-6,916,778.71-21,705,538.24
五、现金及现金等价物净增加额-358,081,180.78-558,841,014.35-5,351,447,517.01-5,438,054,513.77
  加:期初现金及现金等价物余额2,048,493,852.842,048,493,852.847,399,941,369.857,399,941,369.85
  期末现金及现金等价物余额1,690,412,672.061,489,652,838.492,048,493,852.841,961,886,856.08
补充资料:
  净利润362,828,303.84-447,831,286.97-
  资产减值准备29,310,150.71-34,020,755.81-
  固定资产和投资性房地产折旧64,363,418.85-116,428,764.15-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧64,363,418.85-116,428,764.15-
  无形资产摊销40,155,429-88,792,330.09-
  长期待摊费用摊销21,241,046.6-39,895,400.15-
  处置固定资产、无形资产和其他长期资产的损失-625,757.46--3,563,278.83-
  公允价值变动损失89,643,957.92-501,688,166.32-
  财务费用69,211,216.51-123,213,890.6-
  投资损失-233,000,832.99--166,642,230.65-
  递延所得税-25,274,854.86--6,757,746.83-
  其中:递延所得税资产减少-7,790,596.03-11,612,941.68-
    递延所得税负债增加-17,484,258.83--18,370,688.51-
  存货的减少-21,172,493.35-3,658,293.2-
  经营性应收项目的减少-229,911,780.62--1,016,962,949.53-
  经营性应付项目的增加151,014,505.74-751,590,196.71-
  其他32,109,629.89-64,889,880.19-
  现金的期末余额1,690,412,672.06-2,048,493,852.84-
  减:现金的期初余额2,048,493,852.84-7,399,941,369.85-
  现金及现金等价物的净增加额-358,081,180.78--5,351,447,517.01-
公告日期2025-08-292025-04-292025-03-282024-10-30
审计意见(境内)标准无保留意见
TOP↑